Simvastatin
Product Images NDC 43353-856

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 43353-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40mg (43353 856)

Bottle Label 40mg (43353 856)
Simvastatin is a medication available in a bottle of 90 tablets each containing 40mg of the active ingredient. The NDC number is 43353-0856-60. It is manufactured by Aurolife Pharma LLC in Dayton, NJ, and repackaged by Aphena Pharma in Cookesile, TN. The medication should be stored at a temperature between 20-25 degrees Celsius and kept out of the reach of children. The batch number is 2P with the lot number N 43353-0856-60. There is additional information written in code which could not be interpreted.*
FDA Label Image

Bottle Label 80mg (43353 858)

Bottle Label 80mg (43353 858)
Simvastatin 80mg 540 tablets are available in a batch of 2 from Aurolife Pharma LLC in Dayton NJ. They should be stored between 20-25 degrees Celsius and out of reach of children. The lot number is N 43353-0858-98 and they have been repackaged by Aphena Pharma in Cookesville, TN 38506.*
FDA Label Image

Bottle Label 10mg (43353 860)

Bottle Label 10mg (43353 860)
Simvastatin is a medication that comes in the form of tablets. This particular bottle contains 45 tablets each with a dose of 10mg. The NDC number of this medication is 43353-0860-45, while the batch number is 2. The medication should be stored at a temperature between 20-25 degrees C (6377 degrees F) and should be kept away from children. This medication was manufactured by Aurolife Pharma, LLC in Dayton, NJ and repackaged by Aphena Pharma in Cookesile, TN 38506. Other information on this bottle includes USP controlled room temperature and a warning to disperse the medication in a shatterproof container. There are also some illegible characters at the end of the text.*
FDA Label Image

Bottle Label 20mg (43353 861)

Bottle Label 20mg (43353 861)
Simvastatin is a medication used to reduce cholesterol and prevent heart disease. This particular package contains 15 tablets, each with a dosage of 20mg. The medication should be stored at a controlled room temperature between 20-25 degrees Celsius. The package was manufactured by Aurolife Pharma, LLC, and repackaged by Aphena Pharma in Cookesile, TN. The batch number is 2 and the lot number is N 43353-0861-1. The medication should be kept out of reach of children.*
FDA Label Image

Bottle Label 5mg (43353 875)

Bottle Label 5mg (43353 875)
Simvastatin is a medication available in 5mg tablets, sold in a bottle containing 30 tablets. It is to be stored at controlled room temperature (20-25°C or 6377°F) and must be kept out of reach from children. The manufacturer is "Aurolife Pharma, LLC" based in Dayton, NJ, and it was repackaged by "Aphena Pharma" located in Cookeville, TN. The batch number is "2P" and it belongs to lot number N 43353-087. The rest of the text is not readable.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin Fig1)

Figure 1  The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin Fig1)
Not available. The text seems to be a table of numerical data and codes that cannot be understood without context or knowledge of the specific study or research to which they pertain.*
FDA Label Image

Chemical Structure (Simvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.